Dyslipidemia in children with chronic kidney disease

Kidney International

Volumn 78, Issue 11, 2010, Pages 1154-1163

  Saland, Jeffrey M ^a   Pierce, Christopher B ^b   Mitsnefes, Mark M ^c   Flynn, Joseph T ^d   Goebel, Jens ^c   Kupferman, Juan C ^e   Warady, Bradley A ^f   Furth, Susan L ^g  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e MAIMONIDES MEDICAL CENTER   (United States)

^f CHILDREN S MERCY HOSPITAL   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular; chronic kidney disease; dyslipidemia; pediatric nephrology

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; AGE; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; TREND STUDY;

EID: 78349305554     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.311     Document Type: Article

References (61)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119.
2. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41: I-IV, S1-91.
3. Saland JM, Ginsberg HN. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 2007; 22: 1095-1112.
4. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-269.
5. Saito T, Oikawa S, Sato H et al. Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants. Nephron 1999; 83: 193-201.
6. Moorhead JF, Chan MK, El Nahas M et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo- interstitial disease. Lancet 1982; 2: 1309-1311.
7. Diamond JR, Karnovsky MJ. A putative role of hypercholesterolemia in progressive glomerular injury. Annu Rev Med 1992; 43: 83-92.
8. Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000; 58: 293-301.
9. Samuelsson O, Attman PO, Knight-Gibson C et al. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 1998; 9: 1482-1488.
10. Kwiterovich Jr PO. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab 2008; 93: 4200-4209.
11. McMahan CA, Gidding SS, Viikari JS et al. Association of pathobiologic determinants of atherosclerosis in youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns Study). Am J Cardiol 2007; 100: 1124-1129.
12. McMahan CA, Gidding SS, Malcom GT et al. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics 2006; 118: 1447-1455.
13. U.S. Renal Data System, (USRDS). Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. USRDS Coordinating Center: Bethesda, MD http://www.usrds.org, 2008.
14. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002; 61: 621-629.
15. Gruppen MP, Groothoff JW, Prins M et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 2003; 63: 1058-1065.
16. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med 2004; 350: 2654-2662.
17. Chow S, Rodgers P. Applet for Drawing 3-Set Proportional Area Venn Diagrams 2009. http://www.cs.kent.ac.uk/people/staff/pjr/EulerVennCircles/ EulerVennApplet.html. Accessed 8 May 2009.
18. Chow S, Rodgers P. Constructing area-proportional venn and euler diagrams with three circles. Euler Designs Workshop 2005, Paris, 2005.
19. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 1998; 32: S142-S156.
20. Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002; 106: 2137-2142.
21. Grundy SM. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol 1995; 75: 45B-52B.
22. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
23. Vaziri ND. Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int 2003; 63: 1964-1976.
24. Simo JM, Castellano I, Ferre N. et al. Evaluation of a homogeneous assay for high-density lipoprotein cholesterol: limitations in patients with cardiovascular, renal, and hepatic disorders. Clin Chem 1998; 44: 1233-1241.
25. North American Pediatric Renal Trials and Collaborative Studies Annual Report. 2008. http://web.emmes.com/study/ped/annlrept/Annual%20Report%20-2008. pdf. Accessed 8 May 2009.
26. Ardissino G, Dacco V, Testa S et al. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 2003; 111: e382-e387.
27. Kari JA, Donald AE, Vallance DT et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468-472.
28. Bennett-Richards KJ, Kattenhorn M, Donald AE et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int 2002; 62: 1372-1378.
29. Lilien MR, Stroes ES, Op't Roodt J et al. Vascular function in children after renal transplantation. Am J Kidney Dis 2003; 41: 684-691.
30. Lilien MR, Koomans HA, Schroder CH. Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol 2005; 20: 200-204.
31. Covic A, Mardare N, Gusbeth-Tatomir P et al. Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant 2006; 21: 729-735.
32. Shroff RC, Donald AE, Hiorns MP et al. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 2007; 18: 2996-3003.
33. Hussein G, Bughdady Y, Kandil ME et al. Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr Nephrol 2008; 23: 2025-2030.
34. Briese S, Claus M, Querfeld U. Arterial stiffness in children after renal transplantation. Pediatr Nephrol 2008; 23: 2241-2245.
35. Muscheites J, Meyer AA, Drueckler E et al. Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol 2008; 23: 2233-2239.
36. Mitsnefes MM, Kimball TR, Witt SA et al. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 2004; 110: 97-101.
37. Litwin M, Wuhl E, Jourdan C et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16: 1494-1500.
38. Milliner DS, Zinsmeister AR, Lieberman E et al. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 1990; 38: 931-936.
39. Pennisi AJ, Heuser ET, Mickey MR et al. Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. Am J Dis Child 1976; 130: 957-961.
40. Nayir A, Bilge I, Kilicaslan I et al. Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 2001; 16: 2041-2047.
41. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105.
42. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
43. U.S. Renal Data System, (USRDS). Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Includes Special Request, Table H.31 H.31 Combined Transplant and Dialysis Groups). USRDS Coordinating Center: Bethesda, MD http://www.usrds.org, 2007.
44. Baigent C, Landry M. Study Of Heart And Renal Protection (SHARP). Kidney Int Suppl 2003: S207-S210.
45. Fellstrom B, Holdaas H, Jardine AG et al. Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney Blood Press Res 2007; 30: 314-322.
46. Statins in Proteinuric Nephropathies Study NCT0019992, referenced online at www.clinicaltrials.gov.
47. Fassett RG, Ball MJ, Robertson IK et al. The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease. BMC Nephrol 2008; 9: 4.
48. Furth SL, Cole SR, Moxey-Mims M et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2006; 1: 1006-1015.
49. Schwartz GJ, Haycock GB, Edelmann Jr CM et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
50. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571-590.
51. Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 2001; 47: 1579-1596.
52. Christensen B, Glueck C, Kwiterovich P et al. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res 1980; 14: 194-202.
53. Hickman TB, Briefel RR, Carroll MD et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998; 27: 879-890.
54. Schwartz GJ, Furth S, Cole SR et al. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 2006; 69: 2070-2077.
55. Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
56. Wong CS, Pierce CB, Cole SR et al. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol 2009; 4: 812-819.
57. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002: 1-190.
58. Bland JM, Altman DG. Transformations, means, and confidence intervals. BMJ 1996; 312: 1079.
59. Cox C, Chu H, Schneider MF et al. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med 2007; 26: 4352-4374.
60. Peterson B, Harrell FE. Partial Proportional Odds Models For Ordinal Response Variables. J R Stat Soc Ser C Appl Stat 1990; 39: 205-217.
61. Stokes M, Davis C, Koch G. Categorical Data Analysis Using the SAS System, 2 edn SAS Institute and John Wiley and Sons: Cary, NC, 2009.